Generic

Lupin gets USFDA approval for generic HIV drug

Novartis sues Cipla for infringing respiratory drug patent

Swiss drugmaker Novartis AG said on Wednesday it had sued India's Cipla Ltd for infringing patents covering its respiratory drug Onbrez, a month after Cipla launched a copy at a fifth of the original drug's price.

Indian pharma under attack: Researchers say cos sending poor quality drugs to Africa

The researchers found 17.5% of samples of the tuberculosis therapy rifampicin sold in Africa tested substandard

Upcoming Games of 2007 - I

Here's our final list...